中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
20期
452-453
,共2页
充血性心力衰竭%洛汀新%老年人
充血性心力衰竭%洛汀新%老年人
충혈성심력쇠갈%락정신%노년인
Congestive heat failure%Lotensin%Old people
目的观察洛汀新(贝那普利)治疗老年人充血性心力衰竭(CHF)的临床效果。方法选取我院于2010年6月至2012年8月收治的80例充血性心力衰竭患者,给予患有充血性心力衰竭老年患者口服洛汀新药物,观察治疗前后患者心率、心胸比、收缩压、舒张压、超声心动图测量左室舒张末内径(LVDD)、左室射血分数(LVEF)以及心功能的变化。结果80例患者通过口服洛汀新药物后,心功能得到了明显的改善,心率、心胸比、收缩压、舒张压相比治疗前有明显的下降,治疗前后患者的效果对比有统计学意义(P<0.05)。结论洛汀新治疗老年人充血性心力衰竭(CHF)具有较好的疗效,患者使用后药物不良反应少,安全性高,在临床应用上值得大力推广。
目的觀察洛汀新(貝那普利)治療老年人充血性心力衰竭(CHF)的臨床效果。方法選取我院于2010年6月至2012年8月收治的80例充血性心力衰竭患者,給予患有充血性心力衰竭老年患者口服洛汀新藥物,觀察治療前後患者心率、心胸比、收縮壓、舒張壓、超聲心動圖測量左室舒張末內徑(LVDD)、左室射血分數(LVEF)以及心功能的變化。結果80例患者通過口服洛汀新藥物後,心功能得到瞭明顯的改善,心率、心胸比、收縮壓、舒張壓相比治療前有明顯的下降,治療前後患者的效果對比有統計學意義(P<0.05)。結論洛汀新治療老年人充血性心力衰竭(CHF)具有較好的療效,患者使用後藥物不良反應少,安全性高,在臨床應用上值得大力推廣。
목적관찰락정신(패나보리)치료노년인충혈성심력쇠갈(CHF)적림상효과。방법선취아원우2010년6월지2012년8월수치적80례충혈성심력쇠갈환자,급여환유충혈성심력쇠갈노년환자구복락정신약물,관찰치료전후환자심솔、심흉비、수축압、서장압、초성심동도측량좌실서장말내경(LVDD)、좌실사혈분수(LVEF)이급심공능적변화。결과80례환자통과구복락정신약물후,심공능득도료명현적개선,심솔、심흉비、수축압、서장압상비치료전유명현적하강,치료전후환자적효과대비유통계학의의(P<0.05)。결론락정신치료노년인충혈성심력쇠갈(CHF)구유교호적료효,환자사용후약물불량반응소,안전성고,재림상응용상치득대력추엄。
Objective To observe the clinical effect of Lotensin , which treats congestive heart failure (CHF) for old people. Methods Selecting 80 old people with CHF reviewed in our hospital from June, 2010 to August, 2012 we gave them oral lotensin. After they take it, we observe the changes of the 80 cases in heart rate, cardiothoracic ratio, systolic pressure, diastolic blood pressure, ultrasonic cardiogram measured left ventricular end-diastolic diameter (LVDD), left ventricular ejection fraction (LVEF) and heart function before and after treatments. Results The heart functions of the 80 cases were greatly improved by taking oral lotensin. The heart rate, cardiothoracic ratio, systolic pressure and diastolic blood pressure were signiifcantly decreased clearly after treatment. The contrast of the effect of the 80 cases before and after treatments were statistically signiifcant(P<0.05). Conclusion Lotensin has good effect on treating CHF for old people, with few adverse reaction, high safety. It is worthy of promotion in clinical application.